Mixed 3Q for Bard; Profit Dwindles

Zacks Equity Research

CR Bard Inc.’s (BCR) third quarter 2012 adjusted earnings of $1.64 per share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago earnings of $1.62 per share (up 1%). Adjusted earnings exclude one-time items such as acquisition-related expenses and asset impairment charges.

In the reported quarter, profit was $129.3 million (or $1.50 a share), down 1% from the year-ago quarter. Higher operating expenses dampened moderate revenue growth in the quarter.




Revenues inched up 1% (up 3% in constant currency) year over year to $722.9 million, but fell short of the Zacks Consensus Estimate of $735 million. Moderate growth across Urology and Oncology product groups was partially offset by declining Vascular sales.


On a geographic basis, revenues in the U.S. dipped 1% to $483.4 million due to sustained softness in the market. However, international sales grew 3% (up 11% in constant currency) to $239.5 million, led by solid sales in Japan and moderate growth in Europe. Moreover, international sales were boosted by double-digit growth in emerging markets.


Segment Analysis


Revenues from the core Vascular segment decreased 3% (up 1% in constant currency) year over year to $202.5 million. Within Vascular, endovascular sales grew 3%. Biopsy sales fell 1% year over year due to the prevailing softness in the U.S. economy. Electrophysiology (“EP”) revenues dropped 4% due to lower EP Lab system sales (down 8%) along with declining disposable EP sales (down 3%) and surgical graft sales (down 6%).


Revenues from peripheral PTA increased 7%, driven by double-digit sales from Chronic Total Occlusion ( CTO) offerings. Vena Cava Filter sales decreased 4% in the reported quarter. Revenues from the stent franchise grew only 5%, as the Japanese competitor, who had pulled back its product line six months ago returned to the market.


Sales from Urology division increased 3% (up 5% in constant currency) to $188.1 million led by the company’s latest targeted temperature management products. Revenues from the basic drainage division were flat in the U.S and up 1% globally. I.C. Foley sales dropped 4% in the U.S and remained flat globally, as these segments faced continued pricing pressure.


Continence segment’s sales were flat year-over-year in the reported quarter, after declining for 10 straight quarters. The company’s fecal management products posted double-digit growth in the quarter, which partially offset the decline in women’s health products sales.  


Urological specialties sales were down 5%, with a 14% fall in brachytherapy sales. Revenues from StatLock catheter stabilization line (15% of total urology sales) declined 4% in the quarter.


The company’s Oncology segment reported revenue growth of 3% (up 4% in constant currency) year over year to $203.9 million, backed by higher international sales. Peripherally inserted central catheters (:PICC) sales climbed 5% (impacted by softness in volume in the U.S.) while Port revenues inched up 2% in the quarter. Revenues from vascular access ultrasound products increased 3% in the reported quarter.


Sales from Surgical Specialties business were $107.7 million, flat year over year (up 2% in constant currency). Soft tissue repair business grew 2%, whereas natural tissue products sales dipped 1% in the quarter. Revenues from hernia fixation business plunged 19%, hurt by increased competition. The performance irrigation business inched down 1% while the hemostasis segment climbed up 7% in the quarter.




Gross margin was 62.3% in the reported quarter compared to 61.8% in the prior year quarter. Operating margin was 24.7% versus 25.3% in the year-ago quarter.


Marketing, selling and administrative expenses (as a percentage of sales) increased to 27.2% from 26.3% a year ago. Research and development expenses, as a percentage of sales, increased to 7.2% from 6.5%.


Balance Sheet


CR Bard ended the third quarter of 2012 with cash, restricted cash and short-term investments of $836.6 million, up 8.7% on a sequential basis. Total debt increased 6.5% sequentially to $1,293 million.




For fourth quarter 2012, CR Bard expects constant currency revenue growth in the range of 0% to 2%. For full year, the company anticipates constant currency revenues growth in the band of 3% and 4%. The company expects adjusted earnings for the fourth quarter to be in a band of $1.64 and $1.68 per share, reflecting 5 cents dilution from the Neomend acquisition. 


The current Zacks Consensus Estimates for revenue and earnings per share for full year 2012 are $2,977 million and $6.63, respectively.


Our View 


C.R. Bard’s well-diversified end markets and a vast product portfolio insulate it from fluctuations in any single therapeutic category. We expect new product launches to drive organic revenue growth and help CR Bard meet its sales objective. We are also impressed by the company’s initiative to expand into emerging markets with attractive growth opportunities.


The company recently entered into a definitive agreement to acquire privately-owned innovative surgical sealants maker, Neomend, Inc. to expand its surgical specialty product line.


However, increasing competition, fluctuating currency, pricing/volume pressure and an overall tough U.S. economy remain areas of concern. C.R. Bard faces strong competition from Boston Scientific ( BSX), and Johnson & Johnson ( JNJ). We currently have a Neutral recommendation on C.R. Bard. The stock currently retains a Zacks #3 Rank, which translates into a short-term “Hold” rating.

Read the Full Research Report on BSX

Read the Full Research Report on BCR

Read the Full Research Report on JNJ

Zacks Investment Research

More From Zacks.com

  • Global Stocks Take a Dive As Trump Surges Ahead of Debate
    Foreign Policy Magazine

    Global Stocks Take a Dive As Trump Surges Ahead of Debate

    Ahead of the first in-person clash between Republican presidential nominee Donald Trump and his Democratic rival Hillary Clinton, stocks around the world traded lower. “Investors are acting extremely nervous with regards to the debate … and it highlights the fact that the markets are not focusing on the health of the economy, interest rates and geopolitical events,” Robert Pavlik, chief market strategist at Boston Private Wealth, told Reuters Monday. In Asia, where many nations risk seeing the Trans Pacific Partnership with the United States disappear after the election, the Shanghai Composite Index in China was down 1.8 percent (China isn’t a signatory to the pact).

  • Are We in a Baby Boomer Retirement Crisis?

    Are We in a Baby Boomer Retirement Crisis?

    Baby boomers, born between 1946 and 1964, are heading into retirement in droves (about 10,000 a day, in fact). Along with the aging of this iconic cohort come lots of data about their poor preparation for their golden years. Insufficient preparedness and lack of financial resources for decades without steady employment paint a gloomy picture for many retirees. Are we facing a Baby Boomer retirement crisis? There may not be an easy answer, but read on for data that helps shed some light into this large generation's economic situation. (For related reading, see: How Baby Boomers Will Change the Way Others Retire.) Baby Boomer Retirement Research GoBankingRates recently published research conducted

  • Astonishing pic of Hillary Clinton shows what we've become

    Astonishing pic of Hillary Clinton shows what we've become

    Technically Incorrect offers a slightly twisted take on the tech that's taken over our lives. Dear famous person, If we want to be seen with you, we'll turn our backs on you. Please don't be offended. It's just that your fame isn't enough for us anymore. We need to attach ourselves to your fame, so that we can post the resulting picture to Twitter, Facebook and Snapchat. That way, we achieve our own sort of mini-fame. Which could be the maximal fame we ever attain. Please forgive me for this missive to the stars. There's a reason: This astounding picture was posted Sunday on Twitter by Hillary For America design lead Victor Ng. He credited the shot to Clinton campaign photographer Barbara Kinney.

  • Business
    Bloomberg Video

    What's Driving the Selloff in the Philippines?

    Sept. 27 -- Hans Sicat, president and chief executive officer at Philippine Stock Exchange, discusses foreign outflows from the country, Philippine stocks and his outlook for the economy. He speaks to Bloomberg's Angie Lau and David Ingles on "Asia Edge."

  • This is your first look at the far more modern 2017 Jeep Compass

    This is your first look at the far more modern 2017 Jeep Compass

    Both of Jeep's midsize offerings, the Compass and Patriot, are getting hella old. Instead of flooding the market with two new offerings, Jeep is rolling out just one, and it's using the Compass name. The 2017 Jeep Compass will be an all-new affair, and it will be built in the company's newly established manufacturing facility in Goiana, Pernambuco, Brazil.

  • A firm with 20 people could make a $3 billion profit
    Business Insider

    A firm with 20 people could make a $3 billion profit

    Cortec Group is poised to make a killing on its investment in a cooler maker if it successfully goes public. The small private-equity firm could make about $3.3 billion on the initial public offering of Yeti Holdings Inc., which could happen as soon as October, according to a story by The Wall Street Journal's Matt Jarzemsky. Cortec invested about $67 million in Yeti back in 2012, which means it could make 50 times its money in four years, The Journal reported.

  • Here's what to do with your hands during a job interview
    Business Insider

    Here's what to do with your hands during a job interview

    In a job interview, every little thing matters — from your ability to make eye contact to the color of your suit. So you'll want to pay extra close attention to what you do with your hands while you're sitting across from your interviewer. Below, we'

  • In gas drilling country, the honeymoon is over on royalties
    Associated Press

    In gas drilling country, the honeymoon is over on royalties

    Jan Brown pores over his royalty statement and wonders where all the money went. A few months ago, the nation's second-largest natural gas producer siphoned $2,201 worth of gas from his 240-acre property — but paid him only $359 after taking deductions for transportation and processing. Brown, 59, who relies on the royalties as his sole source of income, says the deductions are outrageous and claims his lease forbids them.

  • Samsung Tablet Causes Emergency and Diversion on Transatlantic Flight
    ABC News

    Samsung Tablet Causes Emergency and Diversion on Transatlantic Flight

    A Delta flight from Detroit to Amsterdam had to be diverted to Manchester, England, for two hours Saturday into Sunday after smoke and an unknown smell developed in the passenger cabin. A Delta official and a senior U.S. official told ABC News that the emergency on Flight 138 was caused by a Samsung tablet. The Delta official explained that the tablet fell inside a seat and became jammed after the seat either reclined or was returned to its upright position. Underneath the seat cover, the tablet and foam then started smoking, and passengers could smell a strange odor. The flight was diverted to Manchester, where the seat was replaced. After two hours on the ground, the flight was airborne, en

  • The maker of the EpiPen just made a big change to the story it told Congress last week
    Business Insider

    The maker of the EpiPen just made a big change to the story it told Congress last week

    The pharmaceutical company Mylan, which makes the EpiPen, is now saying it understated the profits it derives from the life-saving allergy drug by 60% in a congressional hearing last week, according to The Wall Street Journal. Mylan paid a 7.4% tax rate last year after moving its business to The Netherlands for tax purposes. The company's CEO, Heather Bresch, was called to the House of Representatives to answer for why her company had raised the EpiPen's price by 500% since it purchased the drug in 2007.

  • Philippines' Duterte pivots to China, Russia as investors flee

    Philippines' Duterte pivots to China, Russia as investors flee

    Philippine President Rodrigo Duterte said Monday he would seek closer economic ties with China and Russia, as the local currency and stock market extended declines following Western criticism of his deadly war on crime. The peso hit a seven-year low to the dollar on Monday and foreign investors pulled out from local shares for a 23rd straight day, which analysts said was due to growing uncertainty over Duterte's handling of what has been one of Asia's best-performing economies in recent years. "I will open trade alliances with Russia and China so all you other investors, just go.

  • Is Cisco Systems Stock Really Worth $37? -- The Motley Fool
    The Motley Fool

    Is Cisco Systems Stock Really Worth $37? -- The Motley Fool

    It's often best for investors to largely ignore the stream of upgrades and downgrades coming from analysts. The worst mistake an investor can make is acting on the opinion of others without doing research of his or her own. It can still be useful to see what analysts are saying, but things like price targets should be taken with a grain of salt. Recently, shares of networking-hardware giant Cisco Systems (NASDAQ:CSCO) received a price-target bump from Deutsche Bank. Citing new growth areas like cloud security, Deutsche raised its price target on Cisco stock to $37, up from a previous target of $35. This new price target implies that shares of Cisco could rise 20%. Is Cisco really worth $37 per

  • A Casino Stock Worth the Gamble -- The Motley Fool
    The Motley Fool

    A Casino Stock Worth the Gamble -- The Motley Fool

    The gaming industry has been through a lot of turmoil in the past two years, mainly in the world's largest gaming market of Macau. Gaming revenue in Macau has dropped by half and as new resorts from Melco Crown (NASDAQ:MPEL), Las Vegas Sands (NYSE:LVS), and Wynn Resorts (NASDAQ:WYNN) have been completed, they have spread the revenue that's left among a growing number of resorts. And with MGM Resorts (NYSE:MGM) completing a project next year, the supply problem isn't over yet. But declines in gaming doesn't mean casinos aren't spitting out cash quarter after quarter. In fact, there's some decent value in gaming stocks if you know where to look. Here's how the big four stack up right now. Where

  • Should I Get a FHA Loan or Conventional Mortgage?

    Should I Get a FHA Loan or Conventional Mortgage?

    Federal Housing Administration loans and conventional loans remain the most popular financing types for today's mortgage borrowers. But which program makes the most financial sense for you? Here's how to decide. The Nuts & Bolts of FHA Loans FHA loans

  • World
    WSJ Live

    Hundreds Killed in Aleppo in Fresh Fighting

    Syria and its Russian allies pressed an assault on Aleppo in what the United Nations called the most intense bombing in years of warfare there, and residents said hundreds of civilians had been killed since a cease-fire fell apart last week. Photo: Getty Images.

  • Why Bank of America's Shares Are Tanking Today -- The Motley Fool
    The Motley Fool

    Why Bank of America's Shares Are Tanking Today -- The Motley Fool

    Shares of Bank of America (NYSE:BAC) are off to a forgettable start this week, down more than 3% as the closing bell on Monday approaches. An SEC investigation found that Merrill Lynch caused market disruptions on at least 15 occasions from late 2012 to mid-2014 and violated the Market Access Rule because its internal controls in place to prevent erroneous trading orders were set at levels so high that it rendered them ineffective. For example, Merrill Lynch applied a limit of 5 million shares per order for one stock that only traded around 79,000 shares per day. Other trading strategies had limits set as high as 25 million shares, which Merrill Lynch reduced to 50,000 shares after the SEC's investigation began.

  • Ariad Pharmaceuticals (ARIA) Stock Climbs, Coverage Initiated at Leerink
    The Street

    Ariad Pharmaceuticals (ARIA) Stock Climbs, Coverage Initiated at Leerink

    NEW YORK (TheStreet) -- Shares of Ariad Pharmaceuticals (ARIA) were advancing in late afternoon trading on Monday as Leerink began covering the stock with an "outperform" rating and $20 price target earlier today. "Despite recent strong stock performance, Ariad shares still trade at a discount to other commercial stage oncology biotech companies while the top line is expected to grow above that of its peers with a 35% 2016 to 2018 compound annual growth rate (CAGR)," the firm said. Ariad's brigatinib drug for certain types of lung cancer is "underappreciated" by Wall Street due to its late entry into the market, Leerink said. But the firm said that brigatinib is "well-positioned" to exceed commercial

  • T-Mobile US to Buy Spectrum from Charter Communications

    T-Mobile US to Buy Spectrum from Charter Communications

    Leading U.S. national wireless carrier T-Mobile US Inc. TMUS recently entered into an agreement with cable MSO (multi service operator) Charter Communications Inc. CHTR to acquire a license of 700 MHz A Block spectrum for Eastern Montana from the latter

  • Oracle Slashes Larry Ellison and Co-CEO's Pay Substantially

    Oracle Slashes Larry Ellison and Co-CEO's Pay Substantially

    Shares of Oracle Corporation ORCL have witnessed a moderate rise over the last 12 months. The company’s stock provided a return of 8.8% compared to the S&P 500’s 12.0% over the period. While emerging opportunities in the Software as a Service (Saas) and

  • Why Oil Prices Will Rise More And Sooner Than Most Believe

    Why Oil Prices Will Rise More And Sooner Than Most Believe

    As the September 26 to 28 “informal” meeting of OPEC producers in Algeria draws near, media speculation could easily cause mental anguish. On oil news websites simultaneous headlines claim OPEC will both fail and succeed in capping output. Called by OPEC August 8, the stated purpose of the gathering was, “OPEC continues to monitor developments closely, and is in constant deliberations with all member states on ways and means to help restore stability to the oil market”.

  • Business
    StreetAuthority Network

    2 Gold Miners Beating The S&P 500 By More Than 2,300% In 2016

    From 2012 to the end of 2015, the price of gold fell almost 50%. The price of gold is up 26%, more than a 300% premium to the S&P 500's 6% return. Gold's sudden reversal is being driven by the same trend that's driving the U.S. dollar.

  • Banking analyst Mike Mayo rips Wells Fargo CEO in a scathing note

    Banking analyst Mike Mayo rips Wells Fargo CEO in a scathing note

    Banking analyst Mike Mayo of CLSA said in a note to investors Monday that his firm's support of Wells Fargo Chairman and CEO John Stumpf "is now wavering," in the wake of the fallout from the $185 million secret account settlement. Stumpf's actions so far — covering his initial response through last week's hearing before the Senate Banking Committee — have been "reactionary versus leading," Mayo wrote. Executive pay "clawbacks should be put in place," the analyst added. "We believe Wells Fargo is bigger than the CEO, notwithstanding a good financial track record during his tenure, and there should be no more excuses." Stumpf would stand to walk from the bank with $123.6 million in severance and

  • Business
    U.S.News & World Report

    Is 4 Percent Still the Safest Retirement Amount?

    Back in 1994, William Bergman, a now-retired California financial planner, published a report in the Journal of Financial Planning that pegged 4 percent as the "safest" withdrawal number that would hike the odds of retirees not outliving their money. By and large, Bergman's 4 percent rule was meant to cover 30 years worth of retirement savings. Thus, if a newly-minted 65-year-old retiree could manage to limit annual withdrawals to 4 percent of savings, he or she would still have retirement fund cash available to them by his or her 95th birthday.

  • 6 Key Facts Social Security Doesn't Always Tell Retirees -- The Motley Fool
    The Motley Fool

    6 Key Facts Social Security Doesn't Always Tell Retirees -- The Motley Fool

    Claiming Social Security is one of the most important financial decisions you'll ever make. Many Americans prefer to turn to the Social Security Administration for help in figuring out when to take their Social Security benefits, and the SSA provides a lot of valuable information both on its website and through its personnel. Yet a recent study from the General Accounting Office took a closer look at the way that the SSA interacts with people filing for Social Security benefits, and it found that in the process of handling in-person claims, the SSA's claims specialists didn't always provide all the key information that people need in order to make an informed choice. Below, we'll look at six

  • Business

    LVMH's digital drive takes time despite Apple hire

    When LVMH hired former Apple music executive Ian Rogers to craft a digital strategy, investors may have hoped for some quick results. Almost a year later, aside from drafting in more digitally-savvy people and taking part in a technology start-up fair, his impact on the world's biggest luxury goods group has yet to become visible. Changing mentalities and priorities at LVMH takes time, according to sources close to the 78 billion euro ($88 billion)group controlled by France's richest man, Bernard Arnault.